Thus, the CCL23 chemokine likely has a significant potential to alleviate ER stress by rescuing the UPR-sensors and reducing the pro-inflammatory cytokine profile, diminishing the immunosuppressive HCC tumor microenvironment and enhancing antitumor immunity. Here, CCL23 is linked to neoplasm.